Cargando…

Radiopharmaceuticals for Therapy

This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation.  Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the u...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Knapp, F. F. (Russ) (Autor), Dash, Ashutosh (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New Delhi : Springer India : Imprint: Springer, 2016.
Edición:1st ed. 2016.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-81-322-2607-9
003 DE-He213
005 20220120061724.0
007 cr nn 008mamaa
008 160120s2016 ii | s |||| 0|eng d
020 |a 9788132226079  |9 978-81-322-2607-9 
024 7 |a 10.1007/978-81-322-2607-9  |2 doi 
050 4 |a R895-920 
072 7 |a MMN  |2 bicssc 
072 7 |a MED080000  |2 bisacsh 
072 7 |a MKR  |2 thema 
082 0 4 |a 616.0757  |2 23 
100 1 |a Knapp, F. F. (Russ).  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Radiopharmaceuticals for Therapy   |h [electronic resource] /  |c by F. F. (Russ) Knapp, Ashutosh Dash. 
250 |a 1st ed. 2016. 
264 1 |a New Delhi :  |b Springer India :  |b Imprint: Springer,  |c 2016. 
300 |a XXIV, 347 p. 157 illus., 85 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
520 |a This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation.  Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy.  In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties. 
650 0 |a Nuclear medicine. 
650 0 |a Therapeutics. 
650 0 |a Oncology. 
650 0 |a Endocrinology. 
650 1 4 |a Nuclear Medicine. 
650 2 4 |a Therapeutics. 
650 2 4 |a Oncology. 
650 2 4 |a Endocrinology. 
700 1 |a Dash, Ashutosh.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9788132226062 
776 0 8 |i Printed edition:  |z 9788132226086 
776 0 8 |i Printed edition:  |z 9788132237983 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-81-322-2607-9  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)